AiM Medical Robotics

AiM Medical Robotics is a neurosurgical robotics company developing a portable MRI-compatible surgical robot for use in the MRI suite and operating room. The company mission is to bring high levels of precision, automation, and efficiency to neurosurgery, improving outcomes for patients undergoing procedures for functional brain disorders such as Parkinson disease and epilepsy, as well as brain cancer. The robot leverages real-time MRI feedback to guide precision robot-assisted interventions, with the goal of reducing procedure time by up to 50% and eliminating errors, providing cost savings to hospitals. The company has partnered with Brigham and Women Hospital for a first human clinical study for MRI-guided device placement in the brain. Founded in 2018 and headquartered in Fort Lauderdale, United States, AiM Medical Robotics has raised approximately 3.1 million in a Series A round with investors including IQ Capital, Surrey Capital Partners, The Lambda Funds, Triple Ring Technologies, Worcester Polytechnic Institute, The Sontag Foundation, Cancer Research Horizons, New York Angels, and Keiretsu Forum.